Institut de Recherches Cliniques de Montréal, 110 Avenue des Pins Ouest, Montréal, Québec H2W 1R7, Canada.
Département de Biochimie et Médecine Moléculaire, Faculté de Médecine, Université de Montréal, 2900 Boulevard Édouart-Montpetit, Montréal,QuébecH3T 1J4, Canada.
J Proteome Res. 2022 Apr 1;21(4):1073-1082. doi: 10.1021/acs.jproteome.1c00938. Epub 2022 Feb 7.
The PAQosome (particle for arrangement of quaternary structure) is a 12-subunit HSP90 co-chaperone involved in the biogenesis of several human protein complexes. Two mechanisms of client selection have previously been identified, namely, the selective recruitment of specific adaptors and the differential use of homologous core subunits. Here, we describe a third client selection mechanism by showing that RPAP3, one of the core PAQosome subunits, is phosphorylated at several Ser residues in HEK293 cells. Affinity purification coupled with mass spectrometry (AP-MS) using the expression of tagged RPAP3 with single phospho-null mutations at Ser116, Ser119, or Ser121 reveals binding of the unphosphorylated form to several proteins involved in ribosome biogenesis. phosphorylation assays indicate that the kinase CK2 phosphorylates these RPAP3 residues. This finding is supported by data showing that pharmacological inhibition of CK2 enhances the binding of RPAP3 to ribosome preassembly factors in AP-MS experiments. Moreover, the silencing of PAQosome subunits interferes with ribosomal assembly factors' interactome. Altogether, these results indicate that RPAP3 phosphate group addition/removal at specific residues modulates binding to subunits of preribosomal complexes and allows speculating that PAQosome posttranslational modification is a mechanism of client selection.
PAQosome(四级结构排列颗粒)是一种由 12 个亚基组成的 HSP90 共伴侣,参与了几种人类蛋白质复合物的生物发生。先前已经确定了两种客户选择机制,即特异性招募特定接头和同源核心亚基的差异使用。在这里,我们通过显示 PAQosome 的核心亚基之一 RPAP3 在 HEK293 细胞中在几个 Ser 残基上发生磷酸化,描述了第三种客户选择机制。使用带有单个磷酸化缺失突变的 Ser116、Ser119 或 Ser121 的标记 RPAP3 的表达进行亲和纯化结合质谱分析(AP-MS),揭示了未磷酸化形式与几个参与核糖体生物发生的蛋白质的结合。磷酸化测定表明,激酶 CK2 磷酸化这些 RPAP3 残基。这一发现得到了数据的支持,表明 CK2 的药理学抑制增强了在 AP-MS 实验中 RPAP3 与核糖体前体组装因子的结合。此外,PAQosome 亚基的沉默干扰了核糖体组装因子的相互作用组。总之,这些结果表明,RPAP3 在特定残基上的磷酸基团添加/去除调节了与核糖体前复合物亚基的结合,并允许推测 PAQosome 的翻译后修饰是客户选择的一种机制。